Enhancing the Outcome of Skills Training for People With Schizophrenia
Schizophrenia
About this trial
This is an interventional treatment trial for Schizophrenia focused on measuring Psychotic Disorders
Eligibility Criteria
Inclusion Criteria: Diagnosis of schizophrenia or schizoaffective disorder for > 5 years Use of stable dose risperidone, olanzapine, or quetiapine for at least 1 month with no planned medication changes Social Behavior Scale (SBS) score > 45 Willing and able to provide informed consent Exclusion Criteria: Intelligence Quotient < 70 Use of more than one antipsychotic medication Use of benzodiazepines, tricyclic antidepressants, or anticholinergic medication commonly used to treat extrapyramidal symptoms Diagnostic and Statistical Manual (DSM)-IV criteria for alcohol or other substance dependence History of any traumatic brain injury leading to loss of consciousness for > 30 minutes Diagnosis of a comorbid medical condition that could interfere with antipsychotic medication treatment or the ability to complete the study
Sites / Locations
- Hall-Brooke-The Center
- Hall-Brooke Behavioral Health Services